Live from the NIH registry
Studies recruiting near Savannah right now
Top 25 of 176 recruiting studies, sorted by proximity — each links to its official registry page
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Savannah, Georgia (6.1 mi)
· Sponsor: AstraZeneca
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
Atrial Fibrillation
N/A
Interventional 466 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Biosense Webster, Inc.
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 990 participants sought
Research Site — Rincon, Georgia (18.7 mi)
· Sponsor: AstraZeneca
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 150 participants sought
Memorial University Medical Center /ID# 272467 — Savannah, Georgia (6.1 mi)
· Sponsor: AbbVie
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
CenExel iResearch, LLC — Savannah, Georgia (6.1 mi)
· Sponsor: Bristol-Myers Squibb
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
St. Joseph's/Candler Health System ( Site 6021) — Savannah, Georgia (6.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: NRG Oncology
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 241 — Bluffton, South Carolina (23.7 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Children's Oncology Group
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: Wake Forest University Health Sciences
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Septic Shock, Sepsis
Phase 3
Interventional 46 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Vivacelle Bio
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Phase 3
Interventional 780 participants sought
Lewis Cancer and Research Pavilion ( Site 0063) — Savannah, Georgia (6.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms
Phase 3
Interventional 1,630 participants sought
Nancy N. & J.C. Lewis Cancer and Research Pavillion — Savannah, Georgia (6.1 mi)
· Sponsor: Eli Lilly and Company
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 800 participants sought
Research Site — Hinesville, Georgia (27.3 mi)
· Sponsor: AstraZeneca
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: NRG Oncology
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Extensive Stage Lung Small Cell Carcinoma
Phase 2, Phase 3
Interventional 138 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Children's Oncology Group
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
Epiretinal Membrane
N/A
Interventional 400 participants sought
Hilton Head Retina Institute — Hilton Head Island, South Carolina (28.4 mi)
· Sponsor: Jaeb Center for Health Research
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain
Phase 3
Interventional 200 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: NRG Oncology
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
APOL1-Mediated Kidney Disease
Phase 2
Interventional 136 participants sought
Research Site — Savannah, Georgia (6.1 mi)
· Sponsor: AstraZeneca
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
Schizophrenia
Phase 3
Interventional 280 participants sought
Local Institution - 191 — Savannah, Georgia (6.1 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company